...
首页> 外文期刊>Scientific reports. >Diagnostic accuracy of liver stiffness measurement in chronic hepatitis B patients with normal or mildly elevated alanine transaminase levels
【24h】

Diagnostic accuracy of liver stiffness measurement in chronic hepatitis B patients with normal or mildly elevated alanine transaminase levels

机译:慢性乙型肝炎患者肝硬化测量肝硬化患者诊断准确性,丙氨酸转氨酶水平

获取原文
           

摘要

We aimed to evaluate the diagnostic accuracy of liver stiffness measurement (LSM) in 188 chronic hepatitis B (CHB) patients with alanine transaminase (ALT) ≤ twice the upper limit of normal (ULN). Liver fibrosis was staged using METAVIR scoring system. Define significant fibrosis as F2-F4, severe fibrosis as F3-F4, and cirrhosis as F4. To predict F2-F4, the AUROC of LSM was higher than that of APRI (0.86 vs 0.73, p?=?0.001) and FIB-4 (0.86 vs 0.61, p??0.001). To predict F4, the AUROC of LSM was also higher than that of APRI (0.93 vs 0.77, p?=?0.012) and FIB-4 (0.93 vs 0.64, p??0.001). Patients with ALT levels 1–2 ULN had higher cut-off values than patients with normal ALT levels for the diagnosis of F2-F4 (6.5 vs 6 kPa) and F4 (10.2 vs 7.8 kPa). Using cut-off values regardless of ALT levels, the diagnostic accuracy of LSM was 81% for F2-F4, and 89% for F4. Applying ALT-stratified cut-off values, the diagnostic accuracy of LSM was 82% for F2-F4, and 86% for F4. In conclusion, LSM is a reliable noninvasive test for the diagnosis of liver fibrosis. Applying ALT-stratified cut-off values did not enhance diagnostic accuracy of LSM in CHB patients with ALT ≤ 2 ULN.
机译:我们旨在评估188例慢性乙型肝炎(CHB)丙氨酸转氨酶(ALT)≤20℃的肝硬化测量(LSM)的诊断准确性(ALT)≤正常上限(ULN)的两倍。使用Metavir评分系统分阶段阶段进行肝纤维化。将显着的纤维化定义为F2-F4,剧烈纤维化作为F3-F4,以及肝硬化作为F4。为了预测F2-F4,LSM的菌射高于APRI(0.86 Vs 0.73,P≤0.001)和FIB-4(0.86 Vs 0.61,P≤0.001)。为了预测F4,LSM的菌射也高于APRI(0.93 Vs 0.77,P≤0.012)和FIB-4(0.93 Vs 0.64,P≤0.001)。 ALT水平1-2 uln的患者具有比具有正常ALT水平的患者更高的截止值,用于诊断F2-F4(6.5 Vs 6 KPA)和F4(10.2 Vs 7.8 KPA)。使用截止值无论ALT级别如何,LSM的诊断精度为F2-F4为81%,F4为89%。应用Alt-stratified截止值,LSM的诊断精度为F2-F4的82%,F4为86%。总之,LSM是一种可靠的非侵入性试验,用于诊断肝纤维化。应用Alt-stratified截止值并未增强CHB患者的LSM诊断准确性Alt≤2uln。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号